It sounds like science fiction, but it's a real development by our scientists. Moreover, the drug is already ready for clinical use. 
The drug was studied for three years, and the results confirmed the vaccine's safety even with repeated administration. A significant reduction in tumor size and a 60-80% reduction in tumor growth were observed. 
The main difference of the Enteromix vaccine is its personalization: the drug is created based on a "tumor passport" and each patient's individual genetic data. 
Initially, the drug is planned for use in the treatment of colorectal cancer. The mRNA vaccine will also be given to patients with melanoma. Based on positive results, oncologists plan to adapt it to other types of cancer. 
According to the Institute of Clinical Oncology at the Oncology Center of the Russian Academy of Medical Sciences, the first experimental group will likely include patients with advanced cancer.
The vaccine is planned to be free and, after testing, will be included in the mandatory health insurance system. 
Do you think it will help?
Add your comment
You might be interested in:
Ordinary minibus in Italy
A guy made a socket from a photo of his girlfriend
A fluffy cucumber lover
A couple from China showed an unusual camper
In Germany, water geysers were turned on to fight dust
In Canada, a man was detained in a toy jeep
The thief didn’t expect that a woman would detain him
Two girls staged a beautiful dance to live music
In a car repair shop, freon refueling ended in a small
